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We describe the case of a patient presenting with odd neurologic symptoms initially thought to represent 
somatization who was found to have critical hypokalemia manifesting as hypokalemic non-periodic 
paralysis. It was determined that the patient had baseline hypokalemia as a function of alcohol abuse, 
exacerbated by self overmedication with hydrochlorothiazide for elevated blood pressure readings at 
home. The diagnosis was suspected when an electrocardiogram was obtained demonstrating a pseudo-
prolonged QT interval with ST depression, consistent with T-U wave fusion and a QU interval with an 
absent T wave.1 The patient received oral and intravenous potassium and magnesium supplementation 
with resolution of symptoms. [Clin Pract Cases Emerg Med. 2019;3(3):211-214.]
*
†
INTRODUCTION
We report a rare and unusual case of hypokalemic non-
periodic paralysis (HNPP) precipitated by thiazide diuretic 
overuse in the setting of alcoholic malnutrition. HNPP 
associated with thiazide diuretics is extremely rare and reported 
only sparingly in the literature. Unique features of this case 
include the patient’s non-specific presentation, pathognomonic 
electrocardiogram (ECG) changes, and the severity of the 
patient’s hypokalemia and associated hypomagnesemia. The 
patient had complete resolution of symptoms with electrolyte 
repletion in the emergency department (ED). We discuss the 
incidence and mechanism of hypokalemic paralysis and a 
detailed description of the patient’s presentation as a reminder 
for emergency physicians to consider HNPP in the differential 
diagnosis of patients treated with thiazide diuretics presenting 
with neurologic symptoms.
CASE REPORT
A 53-year old female with a history of alcohol abuse, 
anxiety, and hypertension presented to the ED with a chief 
complaint of “I think I’m having a stroke.” The patient reported 
inability to move her face or hands since awaking that morning, 
about 30 minutes prior to arrival. She was immediately assessed 
by physician and nursing staff after triage personnel initiated a 
rapid stroke evaluation.
On physical exam, the patient held her mouth immobile 
and partly open, even while talking. On neurologic exam, 
the patient’s hands and wrists appeared to be flaccid, with 
wrists held in passive flexion. Passive range of motion of all 
extremities was normal with no spasticity. Muscle strength 
was assessed at 1/5 in wrist flexion and extension, and 4/5 
throughout the remainder of the bilateral extremities. She was 
unable to comply with cerebellar testing due to weakness. There 
was no clonus. The rest of the physical exam was unremarkable, 
including vital signs, which demonstrated a heart rate of 96 
beats per minute, blood pressure of 136/88 millimeters of 
mercury, respirations of 16 breaths per minute, and pulse 
oximetry of 99% on room air. The patient was afebrile with an 
oral temperature of 97.6 degrees Fahrenheit.
On further history, the patient reported daily moderate 
alcohol abuse of 2-3 glasses of wine, with her last drink the 
evening prior. She had been poorly compliant with outpatient 
primary care follow-up and had not seen her primary care 
physician (PCP) in nine months. However, she had received 
multiple refills of her prescribed hydrochlorothiazide (HCTZ) 
25 milligrams (mg) twice daily, as well as sertraline 100mg 
daily, her only medications. The patient admitted to intermittent 
medication compliance, but stated that she had been taking 
extra doses of HCTZ recently due to elevated blood pressures 
noted on home sphygmomanometry, with an estimated daily 
dose of 50 – 75 mg of HCTZ.
The differential diagnosis was considered to be broad, 
including an anxiety reaction, somatization, intoxication, 
extrapyramidal side effects due to sertraline, or other metabolic 
derangements. Given her neurologic examination, a cerebral 
vascular accident was thought to be unlikely. Believing 
Clinical Practice and Cases in Emergency Medicine 212 Volume III, no. 3: August 2019
A Case of Thiazide-induced Hypokalemic Paralysis Schell et al.
CPC-EM Capsule
What do we already know about this clinical entity? 
Hypokalemic paralysis is associated with genetic 
channelopathy or thyrotoxicosis. Symptoms of 
weakness or paralysis lead to respiratory failure and 
cardiac arrhythmias.
What makes this presentation of disease 
reportable? 
We present an unusual case of hypokalemic non-
periodic paralysis caused by potassium depletion 
that was related to drug side effects and compounded 
by malnutrition.
What is the major learning point? 
An electrocardiogram may give insight into the cause 
of vague weakness of unclear etiology, such as that 
caused by otherwise-benign thiazide diuretics.
How might this improve emergency medicine 
practice? 
This case reinforces the need for a high index of 
suspicion for electrolyte abnormalities in patients 
with alcohol use disorder or who present with 
vague weakness.
anxiety, somatization, and extrapyramidal side effects to be 
more likely, the treating physician administered 25mg of 
intramuscular diphenhydramine to the patient without any 
significant improvement. Laboratory studies were drawn and 
sent and an ECG obtained (Image).
The patient’s ECG was thought to be concerning for 
hypokalemia, which was confirmed when serum chemistry 
revealed a potassium level of 1.8 milliequivalents per liter 
(mEq/L) (normal 3.5-5.0 mEq/L). Additionally, the patient’s 
magnesium level was found to be critically low at 0.8 mEq/L 
(normal 1.5-2.5 mEq/L). Serum calcium level was 8.1 mg/
deciliter (dL) with an albumin level of 2.9 grams (g)/dL (normal 
3.4 – 5.4 g/dL). Corrected serum calcium was calculated to 
be 9.0 mg/dL (normal 8.5 – 10.2 mg/dL). Serum ethanol was 
undetectable and urine drug screen was negative. The patient’s 
sodium level was 134 mEq/L (normal 135-145 mEq/L). Her 
complete blood count, thyroid stimulating hormone, and 
creatine kinase were within normal limits. She had normal renal 
function. A presumptive diagnosis of HNPP was made and 
potassium and magnesium correction started through oral and 
intravenous (IV) routes.
Following administration of 40 mEq of oral potassium 
chloride, 20 mEq of IV potassium chloride, 800 mg of oral 
magnesium oxide, and 2 grams of IV magnesium sulfate, 
the patient had complete resolution of her symptoms and 
narrowing of corrected QT interval. Potassium and magnesium 
supplementation was continued and the patient was admitted for 
evaluation by internal medicine and nephrology.
The patient received additional magnesium and 
potassium supplementation, and subsequent serum chemistries 
demonstrated resolution of hypokalemia and hypomagnesemia. 
She was evaluated by nephrology, who felt that the cause of 
the patient’s electrolyte abnormalities was likely multifactorial, 
a function of diuretic abuse and alcoholic malnutrition. While 
congenital channelopathies were considered and thought to be 
possible, genetic testing was deferred. The patient’s HCTZ was 
discontinued in lieu of amlodipine 10mg daily and the patient 
started on 20 mEq daily potassium chloride supplementation. She 
was discharged to home and advised to obtain repeat laboratory 
testing with her PCP.
 
DISCUSSION
Hypertension is a major cause of morbidity and 
mortality in the United States. Thiazide diuretics are the most 
commonly prescribed anti-hypertensive medication. Thiazides 
are typically very safe and effectively lower blood pressure 
with few side effects or adverse events.2 Potential side 
effects do exist, however, including renal potassium wasting 
leading to hypokalemia. Thiazides work via disruption of 
sodium/chloride co-transporters in the distal tubule leading 
to increased sodium infiltrate. This increase leads to a 
surge in sodium resorption distally via sodium-potassium/
hydrogen counter transporters and a subsequent urinary loss 
of potassium. This loss of potassium and hydrogen ions can 
potentially lead to hypokalemia and metabolic alkalosis, a 
common co-occurrence.3
Given their mechanism of action, it is well-documented 
that non-potassium sparing diuretics, including thiazides, can 
cause hypokalemia. The first case of hypokalemic paralysis 
caused by thiazides was documented in 1958 in a man 
instructed to take 250 mg HCTZ twice daily for hypertension.4 
Potassium wasting has since been found to be dose-dependent, 
and current guidelines do not recommend a patient take more 
than a total of 100 mg HCTZ per day.
 Even with reduction in dosing, hypokalemia is a potential 
side effect in certain patients taking thiazides, and it is 
associated with increased mortality in hospitalized patients. 
Mild hypokalemia (between 3.5 and 3.0 mEq/L) is typically 
asymptomatic. Below 3.0 mEq/L, patients may experience 
muscle cramping, muscle weakness, myalgias, and malaise. In 
severe hypokalemia (less than 2.5 mEq/L), symptoms can include 
ECG changes, arrhythmias, and paralysis. 5 If left untreated, 
severe hypokalemia can lead to respiratory failure and fatal 
dysrhythmias. However, even in severe cases, up to 50% of 
patients are asymptomatic.6
In the presented case, the patient presented with paralysis 
and ECG changes due to hypokalemia from potassium wasting 
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due to medication-induced renal wasting in the presumed 
setting of alcoholic malnutrition. Hypokalemia as well as 
hypomagnesemia are frequently present in the alcoholic 
patient with prevalence of 12% and 30%, respectively.7 
Hypokalemic paralysis caused by loss of total body potassium 
is typically referred to as hypokalemic non-periodic paralysis. 
Another type of hypokalemic paralysis, caused by inherited 
channelopathies, is called hypokalemic periodic paralysis. 
In contrast to potassium wasting, the channelopathy causes a 
rapid shift of potassium into cells and subsequent paralysis.8 
Genetic channelopathy testing was considered in our patient, 
but was ultimately declined because of the other likely causes of 
hypokalemia including diuretic use and alcoholism.
 As stated above, the overwhelming majority of patients 
taking thiazides do not develop clinically significant 
hypokalemia. It is not completely understood why some patients 
are more sensitive to the potassium lowering effects of thiazides, 
but gastrointestinal absorption likely plays a role. Differences in 
dietary potassium intake and other factors affecting potassium 
absorption, such as chronic alcohol use, laxative use, and bulimia 
nervosa put a patient at higher risk for developing hypokalemia.9
It was the ECG obtained in this case that sparked initial 
concern for hypokalemia in this patient. Several classic 
hypokalemia ECG findings are noted in this case including 
diffuse ST depressions, as well as diffuse flattening of the T 
waves with the beginnings of T wave inversions in some lateral 
leads. Prominent U waves are seen following the flattened T 
waves in the precordial and lateral leads. The flattening of the 
T wave in conjunction with the prominent U wave can give the 
impression of an isolated prolonged QT, which should not be 
confused with the ECG manifestations of hypocalcemia. Not 
well visualized in this case is the increase in length and amplitude 
of the P wave or the significant T wave inversions which give a 
biphasic appearance to the TU segment. 
As outlined previously, thiazide-induced HNPP is driven 
primarily by whole body depletion of potassium. Successful 
treatment in this case (and severe hypokalemia in general) 
focuses on rapid repletion of potassium in addition to magnesium. 
Oral formulations of potassium chloride are generally preferred 
to their IV counterparts; however, the IV route should be used 
in patients unable to tolerate oral medication or with cardiac 
arrhythmias or acute respiratory failure.10 This patient received 
rapid IV infusion due to ECG changes concerning for a 
developing cardiac arrhythmia. 
Equally important to potassium administration is 
the requirement for magnesium coadministration to 
correct the hypomagnesemia that frequently accompanies 
hypokalemia. Potassium chloride administration is futile 
in the untreated hypomagnesemic patient as magnesium 
is critical in maintaining intracellular potassium levels.11 
Recommendations on repletion vary; however, administration 
of 2g IV magnesium sulfate, as was done in this case, is 
an accepted initial regimen. Further repletion will often be 
required over the following 24 hours.12 
Image. Electrocardiogram demonstrating a pseudo-prolonged corrected QT interval (522 milliseconds) with ST depression (red arrow), 
consistent with T-U wave fusion and a QU interval with an absent T wave (blue arrow).
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CONCLUSION
While hypokalemic periodic paralysis associated with an 
inherited genetic mutation or thyrotoxicosis is an infrequent but 
well-documented entity, hypokalemic paralysis associated with 
thiazide use – termed hypokalemic non-periodic paralysis – has 
little discussion in the literature. This case report demonstrates 
how a patient presentation that could have been dismissed 
as somatization was actually caused by a severe electrolyte 
abnormality, which can be associated with cardiac arrhythmia 
and respiratory failure. Hypokalemic non-periodic paralysis 
should be considered in the differential diagnosis for patients 
presenting with paralysis who are prescribed thiazide diuretics 
or other potassium-lowering medications. Clinicians should 
have a low threshold to investigate for hypokalemia in patients 
presenting with symptoms suggestive of paralysis.
Documented patient informed consent and/or Institutional Review 
Board approval has been obtained and filed for publication of this 
case report.
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